Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
YourChoice Therapeutics' novel contraceptive YCT-529, targeting retinoic acid receptor-alpha, demonstrated 99% effectiveness in mice and successfully reduced sperm counts in non-human primates.
YourChoice Therapeutics has initiated a Phase Ia/IIb clinical trial of YCT-529, a hormone-free oral contraceptive for men.